Navigation Links
The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009
Date:5/21/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 2Health News:NARAL'S CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARAL's Choice of Barack Obama for President? 2Health News:NARAL'S CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARAL's Choice of Barack Obama for President? 3Health News:PA Homecare Association kicks off Annual Conference: Homecare advocates speak about the importance of re-balancing the healthcare system to ensure care to the citizens of the state 2Health News:World Vision Appealing for $2 Million for Deadly China Quake 2Health News:Study Supports Popular HIV Drug Regimen 2Health News:Study Supports Popular HIV Drug Regimen 3Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 2Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 3
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Anti epilepsy drug risk on cognitive function for unborn children 52256 1Anti epilepsy drug risk on cognitive function for unborn children 52256 2Go to the doctor 3F Only if Im really sick 52254 1Go to the doctor 3F Only if Im really sick 52254 2Researchers design first model motor nerve system thats insulated and organized like the human body 9298 1Researchers design first model motor nerve system thats insulated and organized like the human body 9298 2